LPL Financial’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.81M | Sell |
358,144
-66,946
| -16% | -$339K | ﹤0.01% | 3194 |
|
|
2025
Q1 | $2.25M | Buy |
425,090
+57,305
| +16% | +$303K | ﹤0.01% | 2825 |
|
|
2024
Q4 | $2.49M | Buy |
367,785
+7,347
| +2% | +$49.7K | ﹤0.01% | 2656 |
|
|
2024
Q3 | $2.38M | Buy |
360,438
+40,969
| +13% | +$270K | ﹤0.01% | 2539 |
|
|
2024
Q2 | $2.4M | Buy |
319,469
+111,647
| +54% | +$837K | ﹤0.01% | 2428 |
|
|
2024
Q1 | $2.07M | Buy |
207,822
+68,320
| +49% | +$681K | ﹤0.01% | 2493 |
|
|
2023
Q4 | $1.38M | Buy |
139,502
+71,092
| +104% | +$701K | ﹤0.01% | 2740 |
|
|
2023
Q3 | $523K | Buy |
68,410
+17,205
| +34% | +$132K | ﹤0.01% | 3427 |
|
|
2023
Q2 | $383K | Buy |
51,205
+15,145
| +42% | +$113K | ﹤0.01% | 3629 |
|
|
2023
Q1 | $241K | Sell |
36,060
-9,800
| -21% | -$65.4K | ﹤0.01% | 3885 |
|
|
2022
Q4 | $354K | Buy |
45,860
+4,097
| +10% | +$31.6K | ﹤0.01% | 3518 |
|
|
2022
Q3 | $444K | Sell |
41,763
-474
| -1% | -$5.04K | ﹤0.01% | 3245 |
|
|
2022
Q2 | $344K | Buy |
+42,237
| New | +$344K | ﹤0.01% | 3499 |
|